Cargando…

Renoprotective effects of renin–angiotensin system inhibitor combined with calcium channel blocker or diuretic in hypertensive patients: A PRISMA-compliant meta-analysis

OBJECTIVES: To conduct a meta-analysis of studies comparing the renoprotective effects of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB) combined with either calcium channel blocker (CCB) or diuretic, but not both, in hypertensive patients. DATA SOURCES: Pubmed, Emba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yiming, Huang, Rongshuang, Kim, Sehee, Zhao, Yuliang, Li, Yi, Fu, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	5200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956804/ https://www.ncbi.nlm.nih.gov/pubmed/27428210 http://dx.doi.org/10.1097/MD.0000000000004167

Ejemplares similares

Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease
por: Huang, Rong-Shuang, et al.
Publicado: (2016)

Renin-angiotensin-aldosterone system blockers in Bulgarian COVID-19 patients with or without chronic kidney disease
por: Filev, Rumen, et al.
Publicado: (2022)

The diagnostic accuracy of urinary [TIMP-2]·[IGFBP7] for acute kidney injury in adults: A PRISMA-compliant meta-analysis
por: Liu, Chao, et al.
Publicado: (2017)

Protocol of randomized control trial for effectiveness of angiotensin receptor blockers on blood pressure control among euvolemic hypertensive hemodialysis patients
por: Aftab, Raja Ahsan, et al.
Publicado: (2017)

Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study
por: Chen, Keliang, et al.
Publicado: (2017)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Effect of intrarenal renin-angiotensin-aldosterone system on renal function in patients after cardiac surgery
por: Niu, Peiyuan, et al.
Publicado: (2022)

Effect of Calcium Channel Blockers versus Diuretics for Hypertension
por: Chunxue, Yi, et al.
Publicado: (2022)

Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents and beta-blockers: An electronic health records network study
por: Harrison, Paul J, et al.
Publicado: (2020)

Effects of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on all-cause mortality, cardiovascular death, and cardiovascular events among peritoneal dialysis patients: A protocol for systematic review
por: Nochaiwong, Surapon, et al.
Publicado: (2020)

Efficacy and safety of dual vs single renin–angiotensin–aldosterone system blockade in chronic kidney disease: An updated meta-analysis of randomized controlled trials
por: Zhao, Mingming, et al.
Publicado: (2021)

Primary prevention of cardiovascular disease events with renin-angiotensin system blockade in autosomal dominant polycystic kidney disease dialysis patients: A nationwide cohort study
por: Lu, Chien-Lin, et al.
Publicado: (2021)

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
por: Cho, Min Ae, et al.
Publicado: (2020)

Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
por: Yamamoto, Eiichiro, et al.
Publicado: (2012)

Effects of L-/N-Type Calcium Channel Blockers on Angiotensin II–Renin Feedback in Hypertensive Patients
por: Kawabata, Yutaka, et al.
Publicado: (2020)

Artificial intelligence with kidney disease: A scoping review with bibliometric analysis, PRISMA-ScR
por: Park, Sihyung, et al.
Publicado: (2021)

Correction: Calcium Channel Blockers, More than Diuretics, Enhance Vascular Protective Effects of Angiotensin Receptor Blockers in Salt-Loaded Hypertensive Rats
por: Yamamoto, Eiichiro, et al.
Publicado: (2013)

The effect of calcineurin inhibitors in the treatment of IgA nephropathy: A systematic review and meta-analysis (PRISMA)
por: Peng, Wei, et al.
Publicado: (2016)

Fixed-Dose Combinations of Renin–Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
por: Hsiao, Fu-Chih, et al.
Publicado: (2015)

Comparing diagnostic accuracy of biomarkers for acute kidney injury after major surgery: A PRISMA systematic review and network meta-analysis
por: Lan, Hui, et al.
Publicado: (2023)

Association between diuretic administration before diagnosis and incidence of acute kidney injury in patients with minimal change disease: A single-center observational study
por: Shimamura, Yoshinosuke, et al.
Publicado: (2021)

Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty: A systematic review and meta-analysis (PRISMA)
por: Heshmatzadeh Behzadi, Ashkan, et al.
Publicado: (2021)

Rituximab shows no effect on remission in patients with refractory nephrotic syndrome: A MOOSE-compliant meta-analysis
por: Yin, Supei, et al.
Publicado: (2016)

Visit-to-Visit Variability and Seasonal Variation in Blood Pressure With Single-Pill Fixed-Dose Combinations of Angiotensin II Receptor Blocker/Calcium Channel Blocker and Angiotensin II Receptor Blocker/Diuretic in Hypertensive Patients
por: Shiga, Yuhei, et al.
Publicado: (2015)

Interaction Between Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Angiotensin-Converting Enzyme Inhibition on Survival in Hemodialyzed Patients
por: Kiss, István, et al.
Publicado: (2014)

Association of Megsin Gene Variants With IgA Nephropathy in Northwest Chinese Population: A STROBE-Compliant Observational Study
por: Wei, Lin-Ting, et al.
Publicado: (2016)

Clinicopathologic characteristics, treatment, and outcomes of tubulointerstitial nephritis and uveitis syndrome in adults: A national retrospective strobe-compliant study
por: Legendre, Mathieu, et al.
Publicado: (2016)

Estimation of renal function by three CKD-EPI equations in Chinese HIV/AIDS patients: A STROBE-compliant article
por: Zhao, Naxin, et al.
Publicado: (2021)

Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic
por: Volpe, Massimo, et al.
Publicado: (2012)

Febuxostat combined with hydration for the prevention of contrast-induced nephropathy in hyperuricemia patients undergoing percutaneous coronary intervention: A CONSORT-compliant randomized controlled trial
por: Ma, Guang, et al.
Publicado: (2022)

The relationships of sleep apnea, hypertension, and resistant hypertension on chronic kidney disease
por: Chang, Chih-Ping, et al.
Publicado: (2016)

Calcium dobesilate-induced hyperpyrexia: A case report
por: Yang, Hui, et al.
Publicado: (2023)

Diuretic and β-Blocker in Hypertension—Then What?
por: Ramsay, L. E.
Publicado: (1980)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Early critical cortical infarction by anti-angiotensin II type 1 receptor antibody: A case report and literature review
por: Lim, Jeong-Hoon, et al.
Publicado: (2021)

Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness
por: Kiuchi, Shunsuke, et al.
Publicado: (2015)

Impact of Dialysate Calcium Concentration on Clinical Outcomes in Incident Hemodialysis Patients
por: Kim, Hyung Wook, et al.
Publicado: (2015)

Calcium channel blocker monotherapy versus combination with renin-angiotensin system inhibitors on the development of new-onset diabetes mellitus in hypertensive Korean patients
por: Kim, Yong Hoon, et al.
Publicado: (2019)

Development and Validation of a Medication Selection Model Under Clinical Application of Renin-Angiotensin Inhibitor Combined with Calcium Channel Blocker for Hypertension Patients
por: Hong, Dongsheng, et al.
Publicado: (2020)

Alteration and association between serum ACE2/ angiotensin(1-7)/Mas axis and oxidative stress in chronic kidney disease: A pilot study
por: Shi, Chengqian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_toatuepl5j5oj22pjqlg1s1804